MTOR and cancer: Understanding the cancer-specific effects of sirolimus would help with understanding the etiologic role of the mTOR pathway, and would also inform decisions about immunosuppressant use for recipients with known cancer-risk factors, for whom the advantages of sirolimus use might outweigh possible disadvantages.